Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
36 /100
MEDIUM RISK
Score updated Aug 28, 2026

SMTI — Sanara MedTech Inc. Dilution Risk Tracker

Track SMTI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SMTI — Get alerts when the score changes →

As of August 28, 2026, Sanara MedTech Inc. (SMTI) has a DilutionWatch DilutionScore of 36/100, rated MEDIUM dilution risk. Sanara MedTech Inc. has a market capitalization of $208.85M, 9.19M shares outstanding, 65 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
25
📊 Float Risk
45
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for SMTI.
🔔 Track SMTI — Get forecast alerts →

Market Data

Market Cap$208.85M
Shares Outstanding9.19M
Float4.74M
Cash$15.42M
Debt$49.48M
Short InterestN/A

Institutional Holdings

QoQ: ↓ 7.2% shares (2026Q1 vs prior)
65 institutional holders · 1.79M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 302.7K shares
#2 BlackRock, Inc. 228.8K shares
#3 Stonebridge Wealth Management, LLC 136.9K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest216.1K
Days to Cover1.0
% of Float4.6%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2020-12-31
4 INSIDER TRANSACTION 2026-03-23
4 INSIDER TRANSACTION 2026-03-23
4 INSIDER TRANSACTION 2026-03-23
4 INSIDER TRANSACTION 2026-03-23
Full SEC filing analysis available with free account

Recent News

No recent news

Factual SMTI Dilution Snapshot

Sanara MedTech Inc. (SMTI) has a DilutionScore of 36/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track SMTI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SMTI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations